Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
Tumor genetics guides patient selection for many new therapies, and cell culture studies have demonstrated that specific mutations can promote metabolic phenotypes. However, whether tissue context defines cancer dependence on specific metabolic pathways is unknown. Kras activation and Trp53 deletion...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
American Association for the Advancement of Science (AAAS)
2018
|
Online Access: | http://hdl.handle.net/1721.1/116559 https://orcid.org/0000-0002-8607-1787 https://orcid.org/0000-0002-8206-8003 https://orcid.org/0000-0001-9587-0233 https://orcid.org/0000-0003-4250-7355 https://orcid.org/0000-0002-7702-5877 https://orcid.org/0000-0001-5785-8911 https://orcid.org/0000-0002-6702-4192 |
Internet
http://hdl.handle.net/1721.1/116559https://orcid.org/0000-0002-8607-1787
https://orcid.org/0000-0002-8206-8003
https://orcid.org/0000-0001-9587-0233
https://orcid.org/0000-0003-4250-7355
https://orcid.org/0000-0002-7702-5877
https://orcid.org/0000-0001-5785-8911
https://orcid.org/0000-0002-6702-4192